bf/NASDAQ:VNDA_icon.jpeg

NASDAQ:VNDA

Vanda Pharmaceuticals Inc.

  • Stock

USD

Last Close

4.41

06/11 21:01

Market Cap

303.21M

Beta: 0.70

Volume Today

346.29K

Avg: 585.01K

PE Ratio

17.10

PFCF: 7.88

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
50.16M
-
109.92M
119.16%
146.02M
32.83%
165.08M
13.06%
193.12M
16.98%
227.19M
17.64%
248.17M
9.23%
268.68M
8.27%
254.38M
5.32%
192.64M
24.27%
198.77M
3.18%
cost of revenue
1.58M
-
23.46M
1,382.12%
24.71M
5.33%
17.85M
27.78%
20.51M
14.90%
24.49M
19.41%
23.36M
4.59%
25.63M
9.69%
24.28M
5.26%
11.31M
-
gross profit
48.57M
-
86.46M
78.00%
121.31M
40.30%
147.24M
21.38%
172.61M
17.23%
202.70M
17.43%
224.80M
10.90%
243.05M
8.12%
230.10M
5.33%
192.64M
16.28%
187.46M
2.69%
selling and marketing expenses
general and administrative expenses
84.64M
-
84.53M
0.13%
99.79M
18.05%
123.84M
24.11%
105.75M
14.61%
selling general and administrative expenses
84.64M
-
84.53M
0.13%
99.79M
18.05%
123.84M
24.11%
105.75M
14.61%
129.74M
22.68%
140.51M
8.30%
124.05M
11.72%
136.49M
10.03%
112.88M
17.29%
146.41M
29.70%
research and development expenses
19.23M
-
29.14M
51.56%
29.16M
0.04%
38.55M
32.21%
43.59M
13.09%
48.65M
11.60%
55.58M
14.24%
75.36M
35.60%
85.77M
13.81%
76.82M
10.43%
74.43M
3.11%
other expenses
124K
-
320K
158.06%
665K
107.81%
1.47M
121.35%
3.61M
145.11%
1.50M
58.29%
1.48M
1.79%
1.48M
0%
1.52M
2.57%
16.89M
1,013.85%
7.27M
56.93%
cost and expenses
107.71M
-
150.11M
39.36%
164.59M
9.64%
181.99M
10.57%
171.38M
5.83%
204.38M
19.25%
220.93M
8.10%
226.52M
2.53%
248.05M
9.51%
206.59M
16.71%
239.43M
15.90%
operating expenses
106.13M
-
126.65M
19.34%
139.88M
10.44%
164.14M
17.35%
150.87M
8.08%
179.89M
19.23%
197.56M
9.83%
200.89M
1.68%
223.77M
11.39%
206.59M
7.68%
228.12M
10.42%
interest expense
-4.97M
-
ebitda
-132.92M
-
-27.21M
79.53%
-7.64M
71.93%
-15.15M
98.39%
23.27M
253.53%
24.32M
4.51%
30.10M
23.80%
43.64M
44.98%
7.84M
82.02%
-13.95M
277.85%
-32.53M
133.14%
operating income
20.06M
-
-40.19M
300.30%
-18.57M
53.79%
-16.90M
8.98%
21.74M
228.60%
22.81M
4.93%
27.24M
19.42%
42.16M
54.80%
6.33M
84.99%
-13.95M
320.45%
-40.66M
191.43%
depreciation and amortization
2.25M
-
12.97M
475.51%
10.93M
15.72%
1.75M
83.99%
1.53M
12.74%
1.50M
1.44%
2.86M
90.30%
1.48M
48.39%
1.52M
2.57%
8.13M
-
total other income expenses net
77.74M
-
320K
99.59%
665K
107.81%
1.47M
121.35%
3.61M
145.11%
6.22M
72.34%
4.42M
28.98%
199K
95.49%
4.97M
2,397.99%
20.29M
308.19%
17.74M
12.58%
income before tax
20.19M
-
-39.87M
297.49%
-17.91M
55.08%
-15.43M
13.82%
25.35M
264.25%
29.03M
14.53%
31.66M
9.05%
42.36M
33.83%
11.30M
73.33%
6.34M
43.90%
-22.92M
461.59%
income tax expense
-77.62M
-
104K
-
136K
30.77%
138K
1.47%
-86.53M
62,799.28%
8.32M
109.61%
9.21M
10.75%
5.03M
45.45%
3.83M
23.78%
-4.02M
204.99%
net income
20.19M
-
-39.87M
297.49%
-18.01M
54.82%
-15.57M
13.56%
25.21M
261.93%
115.55M
358.40%
23.34M
79.80%
33.15M
42.06%
6.28M
81.07%
2.51M
60.02%
-18.90M
853.29%
weighted average shs out
34.77M
-
42.25M
21.50%
43.45M
2.84%
44.74M
2.96%
50.86M
13.69%
53.14M
4.48%
54.43M
2.43%
55.55M
2.06%
56.46M
1.64%
57.52M
1.87%
58.15M
1.10%
weighted average shs out dil
36.69M
-
42.25M
15.16%
43.45M
2.84%
44.74M
2.96%
53.05M
18.58%
54.85M
3.40%
55.19M
0.63%
56.92M
3.14%
56.98M
0.11%
57.60M
1.07%
58.15M
0.96%
eps
0.58
-
-0.94
262.07%
-0.41
56.38%
-0.35
14.63%
0.50
242.86%
2.17
334%
0.43
80.18%
0.60
39.53%
0.11
81.67%
0.04
60.35%
-0.33
856.53%
epsdiluted
0.55
-
-0.94
270.91%
-0.41
56.38%
-0.35
14.63%
0.48
237.14%
2.11
339.58%
0.42
80.09%
0.58
38.10%
0.11
81.03%
0.04
60.40%
-0.33
857.53%

All numbers in USD (except ratios and percentages)